anti-inflammatory protein (Celdara)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-inflammatory protein (Celdara)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial InfarctionSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeldara Medical Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeldara Medical Llc
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionSepsis

Other Information

ATC CodeN/A
Related LinksN/A